CLASS I Drug recall · Reported 30 Apr 2014 · FDA Enforcement Report

Glycopyrrolate (MDV) 0.2 MG/ML Injectable Vials recalled

Brookfield Prescription Center is recalling Glycopyrrolate (MDV) 0.2 MG/ML Injectable Vials, Sterile Serum Vials/Sterile Syringes, distributed in Wisconsin. The recall was initiated on 13 Nov 2013 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #: 10292013@15, Beyond Use Date: 11/28/2013
Quantity recalled25 Vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1252-2014
FDA event ID
67026
Recalling firm
Brookfield Prescription Center, Brookfield, WI
Classification
Class I
Status
Terminated
Recall initiated
13 Nov 2013
FDA classified
21 Apr 2014
Reported
30 Apr 2014
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Sterility

Timeline

13 Nov 2013Recall initiated by company
21 Apr 2014Classified by FDA+159 days
30 Apr 2014Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Glycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials, Sterile Serum Vials/Sterile Syringes, for use by a licensed professional only, not for resale, MD Custom Rx, 19035 W Capitol Dr Ste 105, Brookfield, WI 53045.

Where it was distributed

WI

Wisconsin

Questions about this recall

Why was it recalled?

Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.

Which lots are affected?

Lot #: 10292013@15, Beyond Use Date: 11/28/2013

Where was it sold?

WI

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Brookfield Prescription Center

All 7